{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "30932078", "DateCompleted": {"Year": "2020", "Month": "10", "Day": "05"}, "DateRevised": {"Year": "2021", "Month": "01", "Day": "09"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "04", "Day": "01"}], "Language": ["eng"], "ELocationID": ["5414", "10.1038/s41598-019-41984-7"], "Journal": {"ISSN": "2045-2322", "JournalIssue": {"Volume": "9", "Issue": "1", "PubDate": {"Year": "2019", "Month": "Apr", "Day": "01"}}, "Title": "Scientific reports", "ISOAbbreviation": "Sci Rep"}, "ArticleTitle": "3D-QSAR, Docking, ADME/Tox studies on Flavone analogs reveal anticancer activity through Tankyrase inhibition.", "Pagination": {"StartPage": "5414", "MedlinePgn": "5414"}, "Abstract": {"AbstractText": ["Flavones are known as an inhibitor of tankyrase, a potential drug target of cancer. We here expedited the use of different computational approaches and presented a fast, easy, cost-effective and high throughput screening method to identify flavones analogs as potential tankyrase inhibitors. For this, we developed a field point based (3D-QSAR) quantitative structure-activity relationship model. The developed model showed acceptable predictive and descriptive capability as represented by standard statistical parameters r<sup>2</sup> (0.89) and q<sup>2</sup> (0.67). This model may help to explain SAR data and illustrated the key descriptors which were firmly related with the anticancer activity. Using the QSAR model a dataset of 8000 flavonoids were evaluated to classify the bioactivity, which resulted in the identification of 1480 compounds with the IC<sub>50</sub> value of less than 5\u2009\u00b5M. Further, these compounds were scrutinized through molecular docking and ADMET risk assessment. Total of 25 compounds identified which further analyzed for drug-likeness, oral bioavailability, synthetic accessibility, lead-likeness, and alerts for PAINS & Brenk. Besides, metabolites of screened compounds were also analyzed for pharmacokinetics compliance. Finally, compounds F2, F3, F8, F11, F13, F20, F21 and F25 with predicted activity (IC<sub>50</sub>) of 1.59, 1, 0.62, 0.79, 3.98, 0.79, 0.63 and 0.64, respectively were find as top hit leads. This study is offering the first example of a computationally-driven tool for prioritization and discovery of novel flavone scaffold for tankyrase receptor affinity with high therapeutic windows."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Metabolic & Structural Biology Department, CSIR-Central Institute of Medicinal and Aromatic Plants, P.O.-CIMAP, Lucknow, 226015, India."}, {"Identifier": [], "Affiliation": "Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India."}], "LastName": "Alam", "ForeName": "Sarfaraz", "Initials": "S"}, {"Identifier": ["0000-0002-7246-8687"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Metabolic & Structural Biology Department, CSIR-Central Institute of Medicinal and Aromatic Plants, P.O.-CIMAP, Lucknow, 226015, India. f.khan@cimap.res.in."}, {"Identifier": [], "Affiliation": "Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, 201002, India. f.khan@cimap.res.in."}], "LastName": "Khan", "ForeName": "Feroz", "Initials": "F"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Sci Rep", "NlmUniqueID": "101563288", "ISSNLinking": "2045-2322"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Flavones"}, {"RegistryNumber": "0", "NameOfSubstance": "Flavonoids"}, {"RegistryNumber": "EC 2.4.2.30", "NameOfSubstance": "Tankyrases"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Algorithms"}, {"QualifierName": [], "DescriptorName": "Catalytic Domain"}, {"QualifierName": [], "DescriptorName": "Cost-Benefit Analysis"}, {"QualifierName": ["chemistry", "metabolism", "pharmacology"], "DescriptorName": "Flavones"}, {"QualifierName": ["chemistry", "metabolism", "pharmacology"], "DescriptorName": "Flavonoids"}, {"QualifierName": ["economics", "methods"], "DescriptorName": "High-Throughput Screening Assays"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Models, Theoretical"}, {"QualifierName": [], "DescriptorName": "Molecular Docking Simulation"}, {"QualifierName": [], "DescriptorName": "Molecular Structure"}, {"QualifierName": ["drug therapy", "metabolism"], "DescriptorName": "Neoplasms"}, {"QualifierName": [], "DescriptorName": "Protein Binding"}, {"QualifierName": [], "DescriptorName": "Protein Domains"}, {"QualifierName": [], "DescriptorName": "Quantitative Structure-Activity Relationship"}, {"QualifierName": ["antagonists & inhibitors", "chemistry", "metabolism"], "DescriptorName": "Tankyrases"}], "CoiStatement": "The authors declare no competing interests."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Haikarainen T, Krauss S, Lehtio L. Tankyrases: structure, function and therapeutic implications in cancer. Current pharmaceutical design. 2014;20:6472\u201388. doi: 10.2174/1381612820666140630101525.", "ArticleIdList": ["10.2174/1381612820666140630101525", "PMC4262938", "24975604"]}, {"Citation": "Hsiao SJ, Smith S. Tankyrase function at telomeres, spindle poles, and beyond. Biochimie. 2008;90:83\u201392. doi: 10.1016/j.biochi.2007.07.012.", "ArticleIdList": ["10.1016/j.biochi.2007.07.012", "17825467"]}, {"Citation": "Lehti\u00f6 L, Chi NW, Krauss S. Tankyrases as drug targets. FEBS Journal. 2013;280:3576\u20133593. doi: 10.1111/febs.12320.", "ArticleIdList": ["10.1111/febs.12320", "23648170"]}, {"Citation": "Riffell JL, Lord CJ, Ashworth A. Tankyrase-targeted therapeutics: Expanding opportunities in the PARP family. Nature Reviews Drug Discovery. 2012;11:923\u2013936. doi: 10.1038/nrd3868.", "ArticleIdList": ["10.1038/nrd3868", "23197039"]}, {"Citation": "Chiappori AA, et al. A randomized phase II study of the telomerase inhibitor imetelstat as maintenance therapy for advanced non-small-cell lung cancer. Annals of Oncology. 2015;26:354\u2013362. doi: 10.1093/annonc/mdu550.", "ArticleIdList": ["10.1093/annonc/mdu550", "PMC4304381", "25467017"]}, {"Citation": "Donigian JR, De Lange T. The role of the poly(ADP-ribose) polymerase tankyrase1 in telomere length control by the TRF1 component of the shelterin complex. Journal of Biological Chemistry. 2007;282:22662\u201322667. doi: 10.1074/jbc.M702620200.", "ArticleIdList": ["10.1074/jbc.M702620200", "17561506"]}, {"Citation": "Seimiya H, Muramatsu Y, Ohishi T, Tsuruo T. Tankyrase 1 as a target for telomere-directed molecular cancer therapeutics. Cancer Cell. 2005;7:25\u201337. doi: 10.1016/j.ccr.2004.11.021.", "ArticleIdList": ["10.1016/j.ccr.2004.11.021", "15652747"]}, {"Citation": "Chang P, Coughlin M, Mitchison TJ. Tankyrase-1 polymerization of poly(ADP-ribose) is required for spindle structure and function. Nature Cell Biology. 2005;7:1133\u20131139. doi: 10.1038/ncb1322.", "ArticleIdList": ["10.1038/ncb1322", "16244666"]}, {"Citation": "Polakis P. Drugging Wnt signalling in cancer. The EMBO Journal. 2012;31:2737\u20132746. doi: 10.1038/emboj.2012.126.", "ArticleIdList": ["10.1038/emboj.2012.126", "PMC3380214", "22617421"]}, {"Citation": "Huang SMA, et al. Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling. Nature. 2009;461:614\u2013620. doi: 10.1038/nature08356.", "ArticleIdList": ["10.1038/nature08356", "19759537"]}, {"Citation": "Chen B, et al. Small molecule-mediated disruption of Wnt-dependent signaling in tissue regeneration and cancer. Nature Chemical Biology. 2009;5:100\u2013107. doi: 10.1038/nchembio.137.", "ArticleIdList": ["10.1038/nchembio.137", "PMC2628455", "19125156"]}, {"Citation": "Waaler J, et al. A novel tankyrase inhibitor decreases canonical Wnt signaling in colon carcinoma cells and reduces tumor growth in conditional APC mutant mice. Cancer Research. 2012;72:2822\u20132832. doi: 10.1158/0008-5472.CAN-11-3336.", "ArticleIdList": ["10.1158/0008-5472.CAN-11-3336", "22440753"]}, {"Citation": "Yashiroda Y, et al. A novel yeast cell-based screen identifies flavone as a tankyrase inhibitor. Biochemical and Biophysical Research Communications. 2010;394:569\u2013573. doi: 10.1016/j.bbrc.2010.03.021.", "ArticleIdList": ["10.1016/j.bbrc.2010.03.021", "20214890"]}, {"Citation": "Batra P, Sharma AK. Anti-cancer potential of flavonoids: recent trends and future perspectives. 3 Biotech. 2013;3:439\u2013459. doi: 10.1007/s13205-013-0117-5.", "ArticleIdList": ["10.1007/s13205-013-0117-5", "PMC3824783", "28324424"]}, {"Citation": "Kuntz ID. Structure-based strategies for drug design and discovery. Science. 1992;257:1078\u20131082. doi: 10.1126/science.257.5073.1078.", "ArticleIdList": ["10.1126/science.257.5073.1078", "1509259"]}, {"Citation": "Ekins S, Mestres J, Testa B. In silico pharmacology for drug discovery: Applications to targets and beyond. British Journal of Pharmacology. 2007;152:21\u201337. doi: 10.1038/sj.bjp.0707306.", "ArticleIdList": ["10.1038/sj.bjp.0707306", "PMC1978280", "17549046"]}, {"Citation": "Verma J, Khedkar V, Coutinho E. 3D-QSAR in Drug Design - A Review. Current Topics in Medicinal Chemistry. 2010;10:95\u2013115. doi: 10.2174/156802610790232260.", "ArticleIdList": ["10.2174/156802610790232260", "19929826"]}, {"Citation": "Da Silva Veras L, Arakawa M, Funatsu K, Takahata Y. 2D and 3D QSAR studies of the receptor binding affinity of progestins. Journal of the Brazilian Chemical Society. 2010;21:872\u2013881. doi: 10.1590/S0103-50532010000500015.", "ArticleIdList": ["10.1590/S0103-50532010000500015"]}, {"Citation": "Narwal M, Haikarainen T, Fallarero A, Vuorela PM, Lehti\u00f6 L. Screening and structural analysis of flavones inhibiting tankyrases. Journal of Medicinal Chemistry. 2013;56:3507\u20133517. doi: 10.1021/jm3018783.", "ArticleIdList": ["10.1021/jm3018783", "23574272"]}, {"Citation": "Nkizinkiko Y, et al. Discovery of potent and selective nonplanar tankyrase inhibiting nicotinamide mimics. Bioorganic and Medicinal Chemistry. 2015;23:4139\u20134149. doi: 10.1016/j.bmc.2015.06.063.", "ArticleIdList": ["10.1016/j.bmc.2015.06.063", "26183543"]}, {"Citation": "Nathubhai A, et al. Structure-activity relationships of 2-arylquinazolin-4-ones as highly selective and potent inhibitors of the tankyrases. European Journal of Medicinal Chemistry. 2016;118:316\u2013327. doi: 10.1016/j.ejmech.2016.04.041.", "ArticleIdList": ["10.1016/j.ejmech.2016.04.041", "27163581"]}, {"Citation": "Narwal M, et al. Discovery of tankyrase inhibiting flavones with increased potency and isoenzyme selectivity. Journal of Medicinal Chemistry. 2013;56:7880\u20137889. doi: 10.1021/jm401463y.", "ArticleIdList": ["10.1021/jm401463y", "24116873"]}, {"Citation": "Shultz MD, et al. Identification of NVP-TNKS656: The use of structure-efficiency relationships to generate a highly potent, selective, and orally active tankyrase inhibitor. Journal of Medicinal Chemistry. 2013;56:6495\u20136511. doi: 10.1021/jm400807n.", "ArticleIdList": ["10.1021/jm400807n", "23844574"]}, {"Citation": "Nathubhai A, Wood PJ, Lloyd MD, Thompson AS, Threadgill MD. Design and discovery of 2-arylquinazolin-4-ones as potent and selective inhibitors of tankyrases. ACS Medicinal Chemistry Letters. 2013;4:1173\u20131177. doi: 10.1021/ml400260b.", "ArticleIdList": ["10.1021/ml400260b", "PMC4027532", "24900625"]}, {"Citation": "Larsson EA, et al. Fragment-based ligand design of novel potent inhibitors of tankyrases. Journal of Medicinal Chemistry. 2013;56:4497\u20134508. doi: 10.1021/jm400211f.", "ArticleIdList": ["10.1021/jm400211f", "23672613"]}, {"Citation": "Kumpan K, et al. Structure-based design, synthesis and evaluation in vitro of arylnaphthyridinones, arylpyridopyrimidinones and their tetrahydro derivatives as inhibitors of the tankyrases. Bioorganic and Medicinal Chemistry. 2015;23:3013\u20133032. doi: 10.1016/j.bmc.2015.05.005.", "ArticleIdList": ["10.1016/j.bmc.2015.05.005", "26026769"]}, {"Citation": "Shultz MD, et al. [1, 2, 4]Triazol-3-ylsulfanylmethyl)-3-phenyl-[1, 2, 4]oxadiazoles: Antagonists of the wnt pathway that inhibit tankyrases 1 and 2 via novel adenosine pocket binding. Journal of Medicinal Chemistry. 2012;55:1127\u20131136. doi: 10.1021/jm2011222.", "ArticleIdList": ["10.1021/jm2011222", "22260203"]}, {"Citation": "Alam S, Khan F. 3D-QSAR studies on Maslinic acid analogs for Anticancer activity against Breast Cancer cell line MCF-7. Scientific Reports. 2017;7:6019. doi: 10.1038/s41598-017-06131-0.", "ArticleIdList": ["10.1038/s41598-017-06131-0", "PMC5519539", "28729623"]}, {"Citation": "Vinter JG. Extended electron distributions applied to the molecular mechanics of some intermolecular interactions. II. Organic complexes. Journal of Computer-Aided Molecular Design. 1996;10:417\u2013426. doi: 10.1007/BF00124473.", "ArticleIdList": ["10.1007/BF00124473", "8951651"]}, {"Citation": "de Jong S. SIMPLS: An alternative approach to partial least squares regression. Chemometrics and Intelligent Laboratory Systems. 1993;18:251\u2013263. doi: 10.1016/0169-7439(93)85002-X.", "ArticleIdList": ["10.1016/0169-7439(93)85002-X"]}, {"Citation": "Floresta G, et al. Hyphenated 3D-QSAR statistical model-scaffold hopping analysis for the identification of potentially potent and selective sigma-2 receptor ligands. European Journal of Medicinal Chemistry. 2017;139:884\u2013891. doi: 10.1016/j.ejmech.2017.08.053.", "ArticleIdList": ["10.1016/j.ejmech.2017.08.053", "28866257"]}, {"Citation": "Alam S, Khan F. QSAR and docking studies on xanthone derivatives for anticancer activity targeting DNA topoisomerase II\u03b1. Drug Design, Development and Therapy. 2014;8:183\u2013195.", "ArticleIdList": ["PMC3916431", "24516330"]}, {"Citation": "Singh A, et al. Diethyl-4,4\u2032-dihydroxy-8,3\u2032-neolign-7,7\u2032-dien-9,9\u2032-dionate exhibits antihypertensive activity in rats through increase in intracellular cGMP level and blockade of calcium channels. European Journal of Pharmacology. 2017;799:84\u201393. doi: 10.1016/j.ejphar.2017.01.044.", "ArticleIdList": ["10.1016/j.ejphar.2017.01.044", "28159537"]}, {"Citation": "Singh S, et al. Synthesis of 3,5-dihydroxy-7,8-dimethoxy-2-(4-methoxyphenyl)benzopyran-4-one derivatives as anticancer agents. Bioorganic and Medicinal Chemistry Letters. 2016;26:5322\u20135327. doi: 10.1016/j.bmcl.2016.09.036.", "ArticleIdList": ["10.1016/j.bmcl.2016.09.036", "27671497"]}, {"Citation": "Kalani K, Chaturvedi V, Alam S, Khan F, Srivastava S. Anti-Tubercular Agents from Glycyrrhiza glabra. Current Topics in Medicinal Chemistry. 2015;15:1043\u20131049. doi: 10.2174/1568026615666150317223323.", "ArticleIdList": ["10.2174/1568026615666150317223323", "25786503"]}, {"Citation": "Daina A, Michielin O, Zoete V. SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports. 2017;7:42717. doi: 10.1038/srep42717.", "ArticleIdList": ["10.1038/srep42717", "PMC5335600", "28256516"]}, {"Citation": "Singh A, et al. Anticancer activity of gallic acid template-based benzylidene indanone derivative as microtubule destabilizer. Chemical Biology and Drug Design. 2016;88:625\u2013634. doi: 10.1111/cbdd.12805.", "ArticleIdList": ["10.1111/cbdd.12805", "27495835"]}, {"Citation": "Alam, S. & Khan, F. QSAR, docking, ADMET, and system pharmacology studies on tormentic acid derivatives for anticancer activity. J. Biomol. Struct. Dyn.36, 2373\u20132390 (2018).", "ArticleIdList": ["28705120"]}, {"Citation": "Alam S, Khan F. Virtual screening, Docking, ADMET and System Pharmacology studies on Garcinia caged Xanthone derivatives for Anticancer activity. Scientific Reports. 2018;8:5524. doi: 10.1038/s41598-018-23768-7.", "ArticleIdList": ["10.1038/s41598-018-23768-7", "PMC5883056", "29615704"]}]}], "History": [{"Year": "2018", "Month": "6", "Day": "22"}, {"Year": "2019", "Month": "3", "Day": "22"}, {"Year": "2019", "Month": "4", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "4", "Day": "2", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "10", "Day": "6", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "4", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["30932078", "PMC6443786", "10.1038/s41598-019-41984-7", "10.1038/s41598-019-41984-7"]}}]}